期刊文献+

包埋NGF的壳聚糖-PLGA双壁微球制备及其相关性能研究 被引量:3

The fabrication and related properties study of chitosan-poly(lactide-co-glycolide)double-walled microspheres loaded with nerve growth factor
原文传递
导出
摘要 目的评估壳聚糖-聚乳酸-聚乙醇酸共聚物[poly(lactide-co-glycolide),PLGA]双壁微球在体外持续缓释具有生物活性的NGF的可行性。方法应用乳化-离子交联方法制备包埋NGF的、具有不同三聚磷酸钠(sodium tripolyphosphate,TPP)交联浓度[1%、3%、10%(W/V)]的壳聚糖-PLGA双壁微球,同时制备包埋NGF的PLGA微球。通过光镜、扫描电镜、激光共聚焦显微镜观察双壁微球的表面及内部形态,并行双壁微球的粒径分析和红外光谱分析。取包埋NGF的PLGA微球或1%、3%、10%TPP浓度交联的包埋NGF的壳聚糖-PLGA双壁微球(分别设为A、B、C、D组),于不同时间点行体外微球降解率测定、微球中NGF缓释率检测;以未包埋NGF的壳聚糖-PLGA双壁微球缓释液(设为A1组)作为对照,比较A1、B、C、D组体外微球缓释液中NGF的生物活性[以缓释液中具有阳性轴突延长反应的大鼠肾上腺嗜铬细胞瘤(PC12)细胞百分比表示]。结果包埋NGF的壳聚糖-PLGA双壁微球呈球形结构,具有相对粗糙的外表面;激光共聚焦显微镜观察示PLGA微球均匀分布于壳聚糖-PLGA双壁微球内;双壁微球的粒径范围为18.5~42.7μm;红外光谱分析结果说明双壁微球中壳聚糖的氨基与TPP中的磷酸基发生了静电反应。体外降解率测定显示,B、C、D组双壁微球降解速度明显快于A组,并随着TPP浓度的增加而逐渐减慢,培养各时间点各组间微球降解率比较差异均有统计学意义(P<0.05)。体外NGF缓释率测定显示,与A组PLGA微球相比,B、C、D组双壁微球以相对较慢的速度缓释NGF,且缓释速度随TPP浓度增加而减慢。除84 d外,各时间点B、C、D组间比较NGF总缓释率差异均有统计学意义(P<0.05)。体外NGF的生物活性评估显示,培养各时间点B、C、D组缓释液中具有阳性轴突延长反应的PC12细胞百分比均显著高于A1组(P<0.05)。培养7、28 d,B、C、D组间比较差异无统计学意义(P>0.05);56、84 d时,C、D组缓释液中具有阳性轴突延长反应的PC12细胞百分比显著高于B组(P<0.05),C、D组间差异无统计学意义(P>0.05)。结论包埋NGF的壳聚糖-PLGA双壁微球在周围神经损伤后的再生方面具有临床应用潜力。 Objective To evaluate the feasibility of the chitosan-poly(lactide-co-glycolide)(PLGA) double-walled microspheres for sustained release of bioactive nerve growth factor(NGF) in vitro. Methods NGF loaded chitosanPLGA double-walled microspheres were prepared by emulsion-ionic method with sodium tripolyphosphate(TPP) as an ionic cross-linker. The double-walled microspheres were cross-linked by different concentrations of TPP [1%, 3%, 10%(W/V)]. NGF loaded PLGA microspheres were also prepared. The outer and inner structures of double-walled microspheres were observed by light microscopy, scanning electron microscopy, confocal laser scanning microscopy,respectively. The size and distribution of microspheres and fourier transform infra red spectroscopy(FT-IR) were analyzed. PLGA microspheres with NGF or chitosan-PLGA double-walled microspheres cross-linked by 1%, 3%, and10%TPP concentration(set as groups A, B, C, and D respectively) were used to determine the degradation ratio of microspheres in vitro and the sustained release ratio of NGF in microspheres at different time points. The bioactivity of NGF(expressed as the percentage of PC12 cells with positive axonal elongation reaction) in the sustained release solution of chitosan-PLGA double-walled microspheres without NGF(set as group A1) was compared in groups B, C, and D.Results The chitosan-PLGA double-walled microspheres showed relative rough and spherical surfaces without aggregation. Confocal laser scanning microscopy showed PLGA microspheres were evenly uniformly distributed in the chitosan-PLGA double-walled microspheres. The particle size of microspheres ranged from 18.5 to 42.7 μm. The results of FT-IR analysis showed ionic interaction between amino groups and phosphoric groups of chitosan in double-walled microspheres and TPP. In vitro degradation ratio analysis showed that the degradation ratio of double-walled microspheres in groups B, C, and D appeared faster in contrast to that in group A. In addition, the degradation ratio of double-walled microsphere in groups B, C, and D decreased when the TPP concentration increased. There were significant differences in the degradation ratio of each group(P<0.05). In vitro sustained release ratio of NGF showed that when compared with PLGA microspheres in group A, double-walled microspheres in groups B, C, and D released NGF at a relatively slow rate, and the sustained release ratio decreased with the increase of TPP concentration. Except for 84 days,there was significant difference in the sustained release ratio of NGF between groups B, C, and D(P<0.05). The bioactivity of NGF results showed that the percentage of PC12 cells with positive axonal elongation reaction in groups B, C, and D was significantly higher than that in group A1(P<0.05). At 7 and 28 days of culture, there was no significant difference between groups B, C, and D(P>0.05);at 56 and 84 days of culture, the percentage of PC12 cells with positive axonal elongation reaction in groups C and D was significantly higher than that in group B(P<0.05), and there was no significant difference between groups C and D(P>0.05). Conclusion NGF loaded chitosan-PLGA double-walled microspheres have a potential clinical application in peripheral nerve regeneration after injury.
作者 戎梦瑶 昌震 欧佳伟 赵松川 曾文 刘琦 RONG Mengyao;CHANG Zhen;OU Jiawei;ZHAO Songchuan;ZENG Wen;LIU Qi(Department of Internal Medicine,the Hospital of Xidian University,Xi’an Shaanxi,710071,P.R.China;Department of Spinal Surgery,Honghui Hospital Affiliated to Medical School of Xi’an Jiaotong University,Xi’an Shaanxi,710054,P.R.China;Department of Neurosurgery,the First Hospital of Yulin,Yulin Shaanxi,718000,P.R.China)
出处 《中国修复重建外科杂志》 CAS CSCD 北大核心 2020年第1期102-108,共7页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目(81501047)~~
关键词 壳聚糖 聚乳酸-聚乙醇酸共聚物 微球 NGF 神经损伤 Chitosan poly(lactide-co-glycolide) microspheres nerve growth factor nerve injury
  • 相关文献

参考文献1

二级参考文献22

  • 1曾春,蔡道章,全大萍,布丽斯,卢华定,李晓峰,史德海.TGF-β1壳聚糖缓释微球的制备和体外检测[J].中山大学学报(医学科学版),2005,26(3):347-350. 被引量:18
  • 2李可欣,陈大为,赵秀丽,王丹蕾,郑畅.分散-交联法制备氟尿嘧啶壳聚糖微球的研究[J].中国药学杂志,2005,40(18):1392-1395. 被引量:7
  • 3郭保林,高青雨.壳聚糖的功能化及其作为生物医用高分子材料的研究进展[J].胶体与聚合物,2006,24(2):30-33. 被引量:6
  • 4张纲,谭颖徽,卢来春,张蓉,王建华,杜俊兰.bFGF-PLA缓释纳米微球的制备及体外释药的研究[J].重庆医学,2006,35(11):1002-1004. 被引量:10
  • 5Okada-Ban M, Thiery JP, Iouanneau J. Fibroblast growth factor-2. Int J Biochem Cell Biol, 2000, 32(3): 263-267.
  • 6Jeon O, Kang S W, Lim HW. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly (1-1actide-co- glycolide) nanospheres and fibringel. Biomaterials, 2005, 8: 30-32.
  • 7Subramanian A, Lin HY, Vu D, et al. Synthesis and evaluation of scaf- folds prepared from chitosan fibers for potential use in cartilage tissue engineering. Biomed Sci Instrum, 2004, 40:117-122.
  • 8Wang AH, Chen XG, Liu CS, et al. Preparation and characteristics of chitosan microspheres in different acetylation as drug carrier system. 1 Microencapsul, 2008, 26(7): 593-602.
  • 9Zhang Y, Cheng X, Whng J, et al. Novel chitosan/collagen scaffold con- taining transforming growth factor-beta 1 DNA for periodontal tissue engineering. Biochem Biophys Res Commun, 2006, 344(1): 362-369.
  • 10Wang QZ, Chen XG, Li ZX, et al. Preparation and blood coagulation evaluation of chitosan microspheres. J Mater Sci Mater Med, 2008, 19 (3): 1371-1377.

共引文献3

同被引文献25

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部